Duo-Duo Lv
Overview
Explore the profile of Duo-Duo Lv including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lv D, Zhou L, Tang H
Exp Mol Med
. 2021 Jan;
53(1):8-18.
PMID: 33462379
Hepatocyte nuclear factor 4α (HNF4α), a member of the nuclear receptor superfamily, is described as a protein that binds to the promoters of specific genes. It controls the expression of...
2.
Lv D, Wang Y, Wang M, Chen E, Tao Y, Zhang D, et al.
Sci Rep
. 2021 Jan;
11(1):655.
PMID: 33436935
The coexistence of HBV infection and hepatic steatosis is a novel characteristic of liver disease. Silibinin capsules (SC) is a silybin-phospholipid complex containing silybin as the bioactive component, which exerts...
3.
Lv D, Wang M, Chen E, Wu D, Tao Y, Zhang D, et al.
Eur J Gastroenterol Hepatol
. 2018 Nov;
31(3):382-388.
PMID: 30383554
Background: A combination of sofosbuvir (SOF)+NS5A inhibitor therapies is the main treatment for patients with hepatitis C virus (HCV) genotype-2 (GT-2) chronic infection, but the data are rarely reported in...
4.
Tao Y, Deng R, Wang M, Lv D, Yuan M, Wang Y, et al.
Virol J
. 2018 Oct;
15(1):150.
PMID: 30285800
Background: Chronic hepatitis C virus (HCV) genotype (GT) 3 infection with advanced liver disease has emerged as a challenging to treat by direct-acting antivirals (DAAs), but the efficacy of DAAs...